History | Community engagement: improving health and wellbeing and reducing health inequalities | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Consultation comments published

Consultation comments and responses (PDF 1.02 MB)

Published:

04 March 2016

Committee list updated

Committee member list (PDF 175 KB)

Published:

07 January 2016

Stakeholder list updated

Stakeholder list (PDF 130 KB)

Published:

02 March 2016

Draft guidance consultation

Draft guideline (PDF 368 KB)

Published:

15 January 2016
Equality impact assessment (PDF 301 KB)

Published:

15 January 2016
Evidence review 1 Ginny Brunton (PDF 1.74 MB)

Published:

15 January 2016
Evidence review 2 Ginny Brunton (PDF 1.73 MB)

Published:

15 January 2016
Evidence review 3 Gillian Stokes (PDF 1.66 MB)

Published:

15 January 2016
Evidence review 4 Anne-Marie Bagnall (PDF 4 MB)

Published:

15 January 2016
Evidence review 5 Angela Harden (PDF 2.27 MB)

Published:

15 January 2016
Expert report 1 Jane South (PDF 525 KB)

Published:

15 January 2016
Expert report 2 Janet Harris (PDF 895 KB)

Published:

15 January 2016
Expert report 3 Chris Nield (PDF 1.32 MB)

Published:

15 January 2016
Expert report 4 Jennie Popay (PDF 2.07 MB)

Published:

15 January 2016
Expert report 5 Ginny Brunton (PDF 709 KB)

Published:

15 January 2016
Health economic analysis 1 (PDF 1.71 MB)

Published:

15 January 2016
Health economic analysis 2 (PDF 1.41 MB)

Published:

15 January 2016
Health economic analysis 3 (PDF 901 KB)

Published:

15 January 2016
Health economic analysis 4 (PDF 880 KB)

Published:

15 January 2016
Evidence statements (PDF 1.03 MB)

Published:

15 January 2016
Evidence review (PDF 1.85 MB)

Published:

15 January 2016

Committee meetings

Committee meeting
Minutes 11 Dec 2014 (PDF 129 KB)

Published:

20 November 2015
Minutes 03 Feb 2015 (PDF 250 KB)

Published:

20 November 2015
Minutes 24 Mar 2015 (PDF 193 KB)

Published:

20 November 2015
Minutes 03&04 Jun 2015 (PDF 290 KB)

Published:

07 January 2016
Minutes 28 Oct 2014 (PDF 183 KB)

Published:

08 February 2016
Minutes 15 Oct 2015 (PDF 104 KB)

Published:

08 February 2016
Minutes 16 Oct 2015 (PDF 135 KB)

Published:

08 February 2016
Minutes 15 Oct 2015 (PDF 104 KB)

Published:

04 March 2016
Minutes 16 Oct 2015 (PDF 135 KB)

Published:

04 March 2016

Final protocol

Final protocol
Primary research report 1 (PDF 616 KB)

Published:

03 July 2015
Final protocol review 1 (PDF 616 KB)

Published:

03 July 2015
Final protocol review 2 (PDF 396 KB)

Published:

03 July 2015
Final protocol review 3 (PDF 152 KB)

Published:

03 July 2015
Final protocol review 4 (PDF 234 KB)

Published:

03 July 2015
Final protocol review 5 (PDF 606 KB)

Published:

03 July 2015
Health economic plan (PDF 88 KB)

Published:

03 July 2015

Call for evidence

Call for evidence information
Final scope (PDF 254 KB)

Published:

30 April 2014

Final scope

Final scope (PDF 254 KB)

Published:

30 April 2014

Stakeholder comments and responses table

Stakeholder comments and responses table (PDF 762 KB)

Published:

30 April 2014

Draft scope consultation

Draft scope consultation information
Draft scope (PDF 248 KB)

Published:

19 February 2014